<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hadj Mohamed A</submitter><funding>Campus France</funding><funding>Ministère de l’Enseignement Supérieur et de la Recherche Scientifique</funding><pagination>660-676</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10880923</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(2)</volume><pubmed_abstract>Triarylmethanes and triazoles constitute privileged structures extensively used in drug discovery programs. In this work, 12 novel triarylmethanes linked to a triazole ring were designed, synthesized, and chemically characterized aiming to target colorectal cancer. The synthetic strategy for triarylmethanes mono- and bi-substituted by a functionalized triazole ring involved a 1,3-dipolar cycloaddition. A preliminary screening in human colorectal cancer cells (HT-29 and HCT116) and murine primary fibroblasts (L929) allowed the selection of the best candidate 9b based on its high inhibition of cancer cell proliferation with an IC&lt;sub>50&lt;/sub> of 11 μM on HT-29 and 14 μM on HCT116 and its non-cytotoxic effects on murine fibroblasts (&lt;100 μM). A deep mechanistic study on various pathways showe</pubmed_abstract><journal>RSC medicinal chemistry</journal><pubmed_title>Colorectal anticancer activity of a novel class of triazolic triarylmethane derivatives.</pubmed_title><pmcid>PMC10880923</pmcid><funding_grant_id>PhD scholarship 964896H (2019–20)</funding_grant_id><funding_grant_id>UTIQUE 2017 37094W</funding_grant_id><funding_grant_id>Eiffel program</funding_grant_id><funding_grant_id>PHC Program</funding_grant_id><pubmed_authors>Msaddek M</pubmed_authors><pubmed_authors>Hadj Mohamed A</pubmed_authors><pubmed_authors>Lagarde N</pubmed_authors><pubmed_authors>Pinon A</pubmed_authors><pubmed_authors>Ricco C</pubmed_authors><pubmed_authors>Goya-Jorge E</pubmed_authors><pubmed_authors>Liagre B</pubmed_authors><pubmed_authors>Mouhsine H</pubmed_authors><pubmed_authors>Veitia MS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Colorectal anticancer activity of a novel class of triazolic triarylmethane derivatives.</name><description>Triarylmethanes and triazoles constitute privileged structures extensively used in drug discovery programs. In this work, 12 novel triarylmethanes linked to a triazole ring were designed, synthesized, and chemically characterized aiming to target colorectal cancer. The synthetic strategy for triarylmethanes mono- and bi-substituted by a functionalized triazole ring involved a 1,3-dipolar cycloaddition. A preliminary screening in human colorectal cancer cells (HT-29 and HCT116) and murine primary fibroblasts (L929) allowed the selection of the best candidate 9b based on its high inhibition of cancer cell proliferation with an IC&lt;sub>50&lt;/sub> of 11 μM on HT-29 and 14 μM on HCT116 and its non-cytotoxic effects on murine fibroblasts (&lt;100 μM). A deep mechanistic study on various pathways showe</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2026-06-03T00:59:42.062Z</modification><creation>2025-04-06T22:29:55.526Z</creation></dates><accession>S-EPMC10880923</accession><cross_references><pubmed>38389891</pubmed><doi>10.1039/d3md00467h</doi></cross_references></HashMap>